ABUS logo

Arbutus Biopharma (ABUS) EBITDA

Annual EBITDA

-$70.99 M
-$9.13 M-14.75%

December 31, 2023

Summary

Performance

1-Year Change

-14.75%

3-Year Change

-22.91%

5-Year Change

-20.45%

15-Year Change

+33.31%

ABUS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.02%
ABUS annual EBITDA is higher than 25.02% of companies in Healthcare sector

High & Low

All-time High

$34.18 M
ABUS annual EBITDA is currently -307.66% below its historical high of $34.18 million

3-Year Low

-$71.64 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABUS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
ABUS next annual earnings announcement is scheduled for Feb 28, 2025

OtherABUSprofitabilitymetrics:

Annual Revenue

$18.14 M
ABUS annual revenue is $18.14 million

Annual Net Income

-$72.85 M
ABUS annual net profit is -$72.85 million

Annual EBIT

-$72.39 M
ABUS annual earnings before interest & taxes is -$72.39 million

Annual EPS

-$0.44
ABUS annual earnings per share is -$0.44

Quarterly EBITDA

-$19.35 M
+$54.00 K+0.28%

September 30, 2024

Summary

Performance

3-Month Change

+0.28%

1-Year Change

-10.73%

3-Year Change

+9.21%

5-Year Change

+9.21%

ABUS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.9%
ABUS quarterly EBITDA is higher than 23.9% of companies in Healthcare sector

High & Low

All-time High

$40.59 M
ABUS quarterly EBITDA is currently -147.67% below its historical high of $40.59 million

3-Year Low

-$21.32 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABUS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
ABUS next earnings announcement is scheduled for Feb 28, 2025

OtherABUSprofitabilitymetrics:

Quarterly Revenue

$1.34 M
ABUS quarterly revenue is $1.34 million

Quarterly Net Income

-$19.72 M
ABUS quarterly net profit is -$19.72 million

Quarterly EBIT

-$19.69 M
ABUS quarterly earnings before interest & taxes is -$19.69 million

Quarterly EPS

-$0.10
ABUS quarterly earnings per share is -$0.10

TTM EBITDA

-$75.14 M
+$337.00 K+0.45%

September 30, 2024

Summary

Performance

3-Month Change

+0.45%

1-Year Change

-3.42%

3-Year Change

-21.47%

5-Year Change

-21.47%

ABUS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.98%
ABUS TTM EBITDA is higher than 23.98% of companies in Healthcare sector

High & Low

All-time High

$34.29 M
ABUS TTM EBITDA is currently -319.12% below its historical high of $34.29 million

3-Year Low

-$75.48 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABUS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
ABUS next earnings announcement is scheduled for Feb 28, 2025

OtherABUSprofitabilitymetrics:

TTM Revenue

$6.74 M
ABUS TTM revenue is $6.74 million

TTM Net Income

-$76.70 M
ABUS TTM net profit is -$76.70 million

TTM EBIT

-$76.55 M
ABUS TTM earnings before interest & taxes is -$76.55 million

TTM EPS

-$0.43
ABUS TTM earnings per share is -$0.43

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$70.99 M
ABUS annual EBITDA is -$70.99 million

Annual Net Income

-$72.85 M
ABUS annual net profit is -$72.85 million

Annual Interest Expense

$459.00 K
ABUS annual interest expense is $459.00 thousand

Annual Income Tax

$0.00
ABUS annual income tax is $0.00

Annual D&A

$1.40 M
ABUS annual depreciation & amortization is $1.40 million

ABUS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.8%-10.7%-3.4%
3 y3 years-22.9%+9.2%-21.5%
5 y5 years-20.4%+9.2%-21.5%

ABUS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-14.8%+0.9%-85.7%+9.2%-23.4%+0.5%
5 y5-year-22.9%+56.3%-85.7%+16.4%-30.1%+53.7%
alltimeall time-307.7%+85.5%-147.7%+92.5%-319.1%+84.7%

Arbutus Biopharma EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$19.35 M(-0.3%)
-$75.14 M(-0.4%)
Jun 2024
-
-$19.41 M(+11.0%)
-$75.48 M(+3.9%)
Mar 2024
-
-$17.48 M(-7.6%)
-$72.66 M(+2.4%)
Dec 2023
-$70.99 M(+14.8%)
-$18.91 M(-4.0%)
-$70.99 M(-3.3%)
Sep 2023
-
-$19.69 M(+18.7%)
-$73.39 M(+4.1%)
Jun 2023
-
-$16.58 M(+4.9%)
-$70.50 M(+4.8%)
Mar 2023
-
-$15.81 M(-25.8%)
-$67.25 M(+8.7%)
Dec 2022
-$61.86 M(-13.6%)
-$21.32 M(+26.9%)
-$61.86 M(+1.6%)
Sep 2022
-
-$16.80 M(+26.0%)
-$60.88 M(-1.9%)
Jun 2022
-
-$13.33 M(+27.9%)
-$62.03 M(-7.3%)
Mar 2022
-
-$10.42 M(-48.8%)
-$66.89 M(-6.6%)
Dec 2021
-$71.64 M(+24.0%)
-$20.33 M(+13.3%)
-$71.64 M(+6.8%)
Sep 2021
-
-$17.95 M(-1.3%)
-$67.06 M(+1.1%)
Jun 2021
-
-$18.19 M(+19.9%)
-$66.30 M(+9.4%)
Mar 2021
-
-$15.17 M(-3.8%)
-$60.60 M(+4.9%)
Dec 2020
-$57.76 M(-64.4%)
-$15.76 M(-8.3%)
-$57.76 M(-11.4%)
Sep 2020
-
-$17.19 M(+37.7%)
-$65.15 M(-54.0%)
Jun 2020
-
-$12.49 M(+1.4%)
-$141.51 M(-6.8%)
Mar 2020
-
-$12.32 M(-46.8%)
-$151.83 M(-6.4%)
Dec 2019
-$162.24 M(+175.3%)
-$23.15 M(-75.3%)
-$162.24 M(+3.5%)
Sep 2019
-
-$93.55 M(+310.2%)
-$156.71 M(+71.4%)
Jun 2019
-
-$22.81 M(+0.3%)
-$91.42 M(+40.8%)
Mar 2019
-
-$22.73 M(+29.0%)
-$64.94 M(+10.2%)
Dec 2018
-$58.94 M(-44.6%)
-$17.62 M(-37.6%)
-$58.94 M(-41.6%)
Sep 2018
-
-$28.26 M(-870.2%)
-$100.87 M(+20.7%)
Jun 2018
-
$3.67 M(-121.9%)
-$83.54 M(-20.4%)
Mar 2018
-
-$16.72 M(-71.9%)
-$104.92 M(-1.4%)
Dec 2017
-$106.44 M(-78.2%)
-$59.56 M(+444.8%)
-$106.44 M(-65.1%)
Sep 2017
-
-$10.93 M(-38.3%)
-$305.39 M(-2.7%)
Jun 2017
-
-$17.71 M(-3.0%)
-$313.76 M(-36.1%)
Mar 2017
-
-$18.25 M(-92.9%)
-$490.67 M(+0.5%)
Dec 2016
-$488.07 M(+523.2%)
-$258.50 M(+1239.1%)
-$488.07 M(+83.9%)
Sep 2016
-
-$19.30 M(-90.1%)
-$265.39 M(-0.3%)
Jun 2016
-
-$194.61 M(+1143.0%)
-$266.08 M(+211.6%)
Mar 2016
-
-$15.66 M(-56.3%)
-$85.38 M(+9.0%)
Dec 2015
-$78.31 M(+141.4%)
-$35.82 M(+79.1%)
-$78.31 M(+47.4%)
Sep 2015
-
-$20.00 M(+43.7%)
-$53.13 M(+33.3%)
Jun 2015
-
-$13.91 M(+61.9%)
-$39.85 M(+13.2%)
Mar 2015
-
-$8.59 M(-19.2%)
-$35.21 M(+8.5%)
DateAnnualQuarterlyTTM
Dec 2014
-$32.44 M(+181.2%)
-$10.63 M(+58.5%)
-$32.44 M(+34.6%)
Sep 2014
-
-$6.71 M(-27.6%)
-$24.10 M(+15.4%)
Jun 2014
-
-$9.27 M(+59.2%)
-$20.89 M(+43.7%)
Mar 2014
-
-$5.82 M(+154.4%)
-$14.54 M(+26.0%)
Dec 2013
-$11.54 M(-133.8%)
-$2.29 M(-34.7%)
-$11.54 M(-136.8%)
Sep 2013
-
-$3.50 M(+20.0%)
$31.34 M(-5.8%)
Jun 2013
-
-$2.92 M(+3.2%)
$33.26 M(-1.8%)
Mar 2013
-
-$2.83 M(-107.0%)
$33.86 M(-1.2%)
Dec 2012
$34.18 M(-452.2%)
$40.59 M(-2663.5%)
$34.29 M(-497.2%)
Sep 2012
-
-$1.58 M(-31.7%)
-$8.63 M(+2.5%)
Jun 2012
-
-$2.32 M(-3.5%)
-$8.43 M(-12.3%)
Mar 2012
-
-$2.40 M(+2.8%)
-$9.60 M(-5.1%)
Dec 2011
-$9.71 M(+74.6%)
-$2.33 M(+69.6%)
-$10.12 M(+164.3%)
Sep 2011
-
-$1.38 M(-60.6%)
-$3.83 M(-17.0%)
Jun 2011
-
-$3.49 M(+19.7%)
-$4.62 M(+1.9%)
Mar 2011
-
-$2.92 M(-173.7%)
-$4.53 M(-17.9%)
Dec 2010
-$5.56 M(-22.3%)
$3.96 M(-283.2%)
-$5.52 M(-51.9%)
Sep 2010
-
-$2.16 M(-36.6%)
-$11.47 M(+2.5%)
Jun 2010
-
-$3.41 M(-12.8%)
-$11.19 M(+21.2%)
Mar 2010
-
-$3.91 M(+96.7%)
-$9.23 M(+38.3%)
Dec 2009
-$7.15 M(-1.0%)
-$1.99 M(+5.8%)
-$6.67 M(+53.7%)
Sep 2009
-
-$1.88 M(+29.6%)
-$4.34 M(-7.0%)
Jun 2009
-
-$1.45 M(+7.0%)
-$4.67 M(-42.2%)
Mar 2009
-
-$1.35 M(-494.6%)
-$8.08 M(+8.7%)
Dec 2008
-$7.23 M(-336.9%)
$343.20 K(-115.6%)
-$7.43 M(-0.8%)
Sep 2008
-
-$2.21 M(-54.6%)
-$7.49 M(+112.0%)
Jun 2008
-
-$4.86 M(+586.1%)
-$3.53 M(-319.2%)
Mar 2008
-
-$708.50 K(-350.1%)
$1.61 M(-30.5%)
Dec 2007
$3.05 M(-85.0%)
$283.30 K(-83.8%)
$2.32 M(+13.9%)
Sep 2007
-
$1.75 M(+513.4%)
$2.04 M(+613.4%)
Jun 2007
-
$285.60 K
$285.60 K
Dec 2006
$20.41 M(+1457.9%)
-
-
Dec 2005
$1.31 M(-107.3%)
-
-
Dec 2004
-$17.90 M(-35.5%)
-
-
Dec 2003
-$27.76 M(+51.2%)
-
-
Dec 2002
-$18.36 M(+46.0%)
-
-
Dec 2001
-$12.57 M(+33.6%)
-
-
Dec 2000
-$9.41 M(+37.0%)
-
-
Dec 1999
-$6.87 M(-11.5%)
-
-
Dec 1998
-$7.76 M
-
-

FAQ

  • What is Arbutus Biopharma annual EBITDA?
  • What is the all time high annual EBITDA for Arbutus Biopharma?
  • What is Arbutus Biopharma annual EBITDA year-on-year change?
  • What is Arbutus Biopharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly EBITDA year-on-year change?
  • What is Arbutus Biopharma TTM EBITDA?
  • What is the all time high TTM EBITDA for Arbutus Biopharma?
  • What is Arbutus Biopharma TTM EBITDA year-on-year change?

What is Arbutus Biopharma annual EBITDA?

The current annual EBITDA of ABUS is -$70.99 M

What is the all time high annual EBITDA for Arbutus Biopharma?

Arbutus Biopharma all-time high annual EBITDA is $34.18 M

What is Arbutus Biopharma annual EBITDA year-on-year change?

Over the past year, ABUS annual EBITDA has changed by -$9.13 M (-14.75%)

What is Arbutus Biopharma quarterly EBITDA?

The current quarterly EBITDA of ABUS is -$19.35 M

What is the all time high quarterly EBITDA for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly EBITDA is $40.59 M

What is Arbutus Biopharma quarterly EBITDA year-on-year change?

Over the past year, ABUS quarterly EBITDA has changed by -$1.88 M (-10.73%)

What is Arbutus Biopharma TTM EBITDA?

The current TTM EBITDA of ABUS is -$75.14 M

What is the all time high TTM EBITDA for Arbutus Biopharma?

Arbutus Biopharma all-time high TTM EBITDA is $34.29 M

What is Arbutus Biopharma TTM EBITDA year-on-year change?

Over the past year, ABUS TTM EBITDA has changed by -$2.49 M (-3.42%)